Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 1296Carcinoma, Non-Small-Cell Lung 793Neoplasms 787Colorectal Neoplasms 760Stomach Neoplasms 586Carcinoma, Hepatocellular 581Prostatic Neoplasms 514Lung Neoplasms 465Pancreatic Neoplasms 422Rectal Neoplasms 336Recurrence 312Neoplasm Metastasis 306Leukemia, Myeloid, Acute 293Colonic Neoplasms 283Multiple Myeloma 280Lymphoma 276Esophageal Neoplasms 273Uterine Cervical Neoplasms 272Ovarian Neoplasms 263Melanoma 246Head and Neck Neoplasms 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 210Brain Neoplasms 194Lymphoma, Large B-Cell, Diffuse 186Nasopharyngeal Carcinoma 182Leukemia 173Lymphoma, Non-Hodgkin 171Liver Neoplasms 165Glioblastoma 160Polycystic Ovary Syndrome 157

Interventions

ganglioside, GD2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interventional × Gaucher Disease × Clear all
NCT04637503 2020-11-19

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Shenzhen Geno-Immune Medical Institute

Phase 1/2 Unknown
100 enrolled
CNS

Gaucher Disease, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡